EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy

Marion Delcroix iD, Joanna Pepke-Zaba, Andrea M D'Armini iD, Elie Fadel iD, Stefan Guth iD, Stephen P Hoole iD, David P Jenkins, David G Kiely iD, Nick H Kim iD, Michael M Madani, Hiromi Matsubara, Kazuhiko Nakayama und 9 weitere

Circulation · 22.10.2024 · 150 (17) · 1354-1365

DOI: 10.1161/circulationaha.124.068610 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation, erschienen am 22.10.2024. Verfasst von Marion Delcroix und 20 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Department of Respiratory Diseases, University Hospitals of Leuven, Belgium (M.D., R.Q.). Hauptthemen laut MEDLINE: Registries, Endarterectomy, Hypertension, Pulmonary, Angioplasty, Balloon. Die Arbeit wurde bisher 109-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The European Chronic Thromboembolic Pulmonary Hypertension (CTEPH) registry, conducted between 2007 and 2012, reported the major impact of pulmonary endarterectomy (PEA) on the long-term survival of patients with CTEPH. Since then, 2 additional treatments for inoperable CTEPH have become available: balloon pulmonary angioplasty (BPA), and an approved oral drug therapy with the guanylate cyclase stimulator riociguat. The current registry aimed to evaluate the effect of these new therapeutic approaches in a worldwide context. METHODS: Participation in this international global registry included 34 centers in 20 countries. Between February 2015 and September 2016, 1009 newly diagnosed, consecutive patients were included and followed until September 2019. RESULTS: Overall, 605 patients (60%) underwent PEA and 185 (18%) underwent BPA; 76% of the 219 remaining patients not receiving mechanical intervention (ie, neither PEA nor BPA) were treated with pulmonary hypertension drugs. Of patients undergoing PEA and BPA, 38% and 78% also received drugs for pulmonary hypertension, respectively. Median age at diagnosis was higher in the BPA and No PEA/BPA groups than in the PEA group: 66 and 69, respectively, versus 60 years. Pulmonary vascular resistance (PVR) was similar in all groups, with an average of 643 dynes.s.cm −5 . During the observation period (>3 years; ≤5.6 years), death was reported in 7%, 11%, and 27% of patients treated by PEA and BPA, and those receiving no mechanical intervention ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesEndarterectomyHypertension, PulmonaryAngioplasty, BalloonPulmonary EmbolismHumansMaleFemaleMiddle AgedAgedTreatment OutcomePulmonary ArteryChronic DiseaseTime Factors

Stichwörter der Autor:innen

angioplasty, balloonendarterectomyhypertension, pulmonaryregistriesvenous thromboembolism

Autor:innen und Institutionen

  • Clinical Department of Respiratory Diseases, University Hospitals of Leuven, Belgium (M.D., R.Q.).
  • Laboratory of Respiratory Diseases and Thoracic Surgery, Department of Chronic Diseases and Metabolism, University of Leuven, Belgium (M.D., R.Q.).
  • Royal Papworth Hospital, Cambridge, UK (J.P-Z., S.P.H., D.P.J.).
  • Division of Cardiac Surgery II and Chronic Thromboembolic Pulmonary Hypertension Center, Cardio-Thoracic and Vascular Department, Foundation IRCCS Policlinico San Matteo, Pavia, Italy (A.M.D.).
  • University of Pavia, School of Medicine, Italy (A.M.D.).
  • Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Marie Lannelongue Hospital, Paris-Saclay University, Le Plessis Robinson, France (E.F.).

ORCID-Profile: Marion Delcroix, Andrea M D'Armini, Elie Fadel, Stefan Guth, Stephen P Hoole, David G Kiely, Nick H Kim, Jaquelina S Ota-Arakaki, Rozenn Quarck, Christoph B Wiedenroth, Bedrettin Yildizeli, Irene M Lang

Zitieren

APA

Delcroix, M., Pepke-Zaba, J., D'Armini, A. M., Fadel, E., Guth, S., Hoole, S. P., Jenkins, D. P., Kiely, D. G., Kim, N. H., Madani, M. M., Matsubara, H., Nakayama, K., Ogawa, A., Ota-Arakaki, J. S., Quarck, R., Sadushi-Kolici, R., Simonneau, G., Wiedenroth, C. B., Yildizeli, B., …, & Lang, I. M. (2024). Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy. Circulation, 150(17), 1354-1365. https://doi.org/10.1161/circulationaha.124.068610

Vancouver

Delcroix M, Pepke-Zaba J, D'Armini AM, Fadel E, Guth S, Hoole SP, et al. Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy. Circulation. 2024;150(17):1354-1365. doi:10.1161/circulationaha.124.068610

BibTeX
@article{Delcroix2024,
  author = {Delcroix, Marion and Pepke-Zaba, Joanna and D'Armini, Andrea M and Fadel, Elie and Guth, Stefan and Hoole, Stephen P and Jenkins, David P and Kiely, David G and Kim, Nick H and Madani, Michael M and Matsubara, Hiromi and Nakayama, Kazuhiko and Ogawa, Aiko and Ota-Arakaki, Jaquelina S and Quarck, Rozenn and Sadushi-Kolici, Roela and Simonneau, Gérald and Wiedenroth, Christoph B and Yildizeli, Bedrettin and Mayer, Eckhard and Lang, Irene M},
  title = {Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy},
  journal = {Circulation},
  year = {2024},
  volume = {150},
  number = {17},
  pages = {1354--1365},
  doi = {10.1161/circulationaha.124.068610}
}
Kostenlos starten →